Navigate to Other Sector


Healthcare Newsletter – December 2017

Gene Therapy Approval Heralds in Era Of Next Generation Therapies
First Herceptin Biosimilar sails through FDA Approval
Hong Kong Overhauls Listing Rules to Attract Innovation-Led Start-ups
Opportunistic M&A, a Mainstream Strategy in Pharma Business
Tough luck for Vaccines following two glorious months of pipeline developments
Regulatory Clarity on 3D Printed Medical Devices

Contact us to know more…

Discussion — No responses

Show Buttons
Hide Buttons